This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Raising awareness of Antimicrobial Resistance (AMR), we present this new podcast series in which Professor Philippe Montravers and Dr Camilla Rodrigues welcome international experts to discuss the challanges and share expertise in managing multi-drug resistant infections in critically ill patients.
Expert guest Professor Peter Hawkey joins hosts Professor Montravers and Dr Rodrigues to explore the development and spread of AMR, how it should be managed and why stewardship and rapid diagnostics are important.
Guest speaker Dr Alex Soriano meets our hosts to look at the incidence of complicated intra-abdominal infections caused by CRE and the associated challenges in treating high-risk patients.
Professor Antoni Torres joins our hosts to discuss the impact of COVID-19 on the number of multi-drug resistant ventilator-associated pneumonia cases especially Pseudomonas aeruginosa while assessing the treatment pathway and viable treatment options in VAP.
Great Ormond Street Hospital's Dr Louis Grandjean, Dr James Hatcher and Orlagh McGarrity discuss treatment in high-risk paediatric complicated intra-abdominal infection cases, challenges of MDR Pseudomonas in this group and investigate available options to paediatric patients
David Livermore talks to our hosts about CRE, its unique challenges in the treatment pathway for high-risk patients with HAP, using β-lactam/β-lactamase inhibitors for CRE infections and available treatment options for carbapenemases OXA-48 and KPC.
The speakers weigh up treatment options for acute pyelonephritis with secondary bacteraemia due to CRE. They discuss polymyxin use in the critically ill and examine β-lactam/β-lactamase inhibitors as viable alternatives. With expert guest Professor Souha Kanj.
We have a variety of educational resources aimed at supporting Healthcare Professsionals looking to enhance their knowledge of AMR and Stewardship.
Get further information on antimicrobial stewardship including a variety of resources for antibacterial and antifungal stewardship on the Anti-infectives section of PfizerPro
CRE, carbapenem resistant enterobacteriaceae; cIAI, complicated intra-abdominal infection; HAP, hospital-acquired pneumonia; VAP, ventilator-associated pneumonia; MDR, multi-drug resistant; AMR, Antimicrobial Resistance; AMS, Antimicrobial Stewardship; AFS, Antifungal Stewardship; ABS, Antibacterial Stewardship
Follow the link to learn about out upcoming meetings and online webinars event - dates, location and agendas.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2023 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-3863. November 2021